/C O R R E C T I O N — Kedrion Biopharma/

/C O R R E C T I O N -- Kedrion Biopharma/

martedì 2 giugno 2026 New tab

1,003 words~5 min read

/C O R R E C T I O N -- Kedrion Biopharma/

PR Newswire

NEW YORK, June 1, 2026

In the news release, Kedrion Biopharma and InstaLILY Convene Industry Leaders to Advance the Future of AI in Healthcare at NY Tech Week, issued 01-Jun-2026 by Kedrion Biopharma over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Kedrion Biopharma and InstaLILY Convene Industry Leaders to Advance the Future of AI in Healthcare at NY Tech Week

/C O R R E C T I O N — Kedrion Biopharma/

/C O R R E C T I O N — Kedrion Biopharma/

Other newsrooms on this story

Related reading

/C O R R E C T I O N — Innovent Biologics/

/C O R R E C T I O N — Ranok Therapeutics/

/C O R R E C T I O N — Radial Health, Inc./

Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes…

Are analysts too quick to gloss over Lilly's liver case?

/C O R R E C T I O N — Vector Sciences & Therapeutics/

Other newsrooms on this story

Related reading

/C O R R E C T I O N — Innovent Biologics/

/C O R R E C T I O N — Ranok Therapeutics/

/C O R R E C T I O N — Radial Health, Inc./

Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes…

Are analysts too quick to gloss over Lilly's liver case?

/C O R R E C T I O N — Vector Sciences & Therapeutics/